High-pro­file R&D spe­cial­ist David Leb­wohl jumps to new job as CMO of a pi­o­neer­ing CRISPR play­er; Trou­bled AM­AG Phar­ma­ceu­ti­cals taps Scott My­ers as CEO

→ No­var­tis vet David Leb­wohl has found a new biotech to ply his trade.

A lit­tle more than a year ago, Leb­wohl joined the great mi­gra­tion out of No­var­tis, leav­ing his post as head of the CAR-T unit in late 2018 to take the CMO job at Sem­ma. Then Ver­tex snapped up Sem­ma and its cut­ting-edge work in re­gen­er­a­tive med­i­cine and now Leb­wohl is head­ed to CRISPR/Cas9 pi­o­neer In­tel­lia as chief med­ical of­fi­cer.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.